Showing results (51-60 of 429) with videos related to
Sort By:
Pageof 43
Expert Opinion on Therapeutic Targets|January 24, 2003
Insights into the structure and function of 5-HT(2) family serotonin receptors reveal novel strategies for therapeutic target developmentBryan L Roth, David A ShapiroFrontiers in Molecular Neuroscience|November 7, 2009
Engineered G-protein Coupled Receptors are Powerful Tools to Investigate Biological Processes and BehaviorsCharles D Nichols, Bryan L RothAmerican Journal of Physiology. Cell Physiology|April 17, 2023
G protein-coupled receptors as targets for transformative neuropsychiatric therapeuticsGavin P Schmitz, Bryan L RothThe American Journal of Psychiatry|May 1, 2023
Psychedelics as Transformative TherapeuticsBryan L Roth, Ryan H GumpperNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 18, 2023
Psychedelics: preclinical insights provide directions for future researchRyan H Gumpper, Bryan L RothNature Reviews. Drug Discovery|March 18, 2022
The promises and perils of psychedelic pharmacology for psychiatryTristan D McClure-Begley, Bryan L RothCurrent Protocols in Neuroscience|January 13, 2010
Generation of designer receptors exclusively activated by designer drugs (DREADDs) using directed molecular evolutionYing Pei, Shuyun Dong, Bryan L RothActa Crystallographica. Section F, Structural Biology Communications|June 10, 2015
Crystallization of interleukin-18 for structure-based inhibitor designBrian Krumm, Xiangzhi Meng, Yan Xiang, et al.Annual Review of Medicine|July 28, 2009
The expanded biology of serotoninMiles Berger, John A Gray, Bryan L RothNature Protocols|March 6, 2010
Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLsShuyun Dong, Sarah C Rogan, Bryan L RothPageof 43